Amyris, Inc. (AMRS): Price and Financial Metrics


Amyris, Inc. (AMRS): $15.66

-0.19 (-1.20%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add AMRS to Watchlist
Sign Up

Industry: Chemicals


Ranked

of 99

in industry

AMRS POWR Grades


  • Growth is the dimension where AMRS ranks best; there it ranks ahead of 74.14% of US stocks.
  • The strongest trend for AMRS is in Growth, which has been heading up over the past 31 weeks.
  • AMRS ranks lowest in Stability; there it ranks in the 3rd percentile.

AMRS Stock Summary

  • The capital turnover (annual revenue relative to shareholder's equity) for AMRS is -1 -- better than only 4.62% of US stocks.
  • AMRS's equity multiplier -- a measure of assets relative to shareholders'equity -- is greater than that of only 5.06% of US stocks.
  • In terms of volatility of its share price, AMRS is more volatile than 97.64% of stocks we're observing.
  • If you're looking for stocks that are quantitatively similar to Amyris Inc, a group of peers worth examining would be OMER, PRTK, TXMD, AQST, and QMCO.
  • AMRS's SEC filings can be seen here. And to visit Amyris Inc's official web site, go to www.amyris.com.

AMRS Valuation Summary

  • In comparison to the median Basic Materials stock, AMRS's price/earnings ratio is 130.74% lower, now standing at -7.9.
  • Over the past 130 months, AMRS's price/sales ratio has gone up $4.6.
  • Over the past 130 months, AMRS's price/sales ratio has gone up $4.6.

Below are key valuation metrics over time for AMRS.

Stock Date P/S P/B P/E EV/EBIT
AMRS 2020-05-05 2.6 -1.5 -1.5 -3.7
AMRS 2017-11-28 1.9 -0.8 -1.1 -3.9
AMRS 2016-01-22 7.3 -1.9 -2.2 -10.7
AMRS 2014-01-27 10.5 327.0 -2.4 -3.3
AMRS 2013-01-03 1.8 2.6 -0.9 -1.2
AMRS 2012-04-23 1.2 1.1 -1.0 -0.7

AMRS Price Target

For more insight on analysts targets of AMRS, see our AMRS price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $23.67 Average Broker Recommendation 1.33 (Strong Buy)

AMRS Stock Price Chart Interactive Chart >

Price chart for AMRS

AMRS Price/Volume Stats

Current price $15.66 52-week high $23.42
Prev. close $15.85 52-week low $1.88
Day low $15.61 Volume 2,154,300
Day high $16.21 Avg. volume 4,508,003
50-day MA $14.51 Dividend yield N/A
200-day MA $9.53 Market Cap 4.62B

Amyris, Inc. (AMRS) Company Bio


Amyris, Inc. provides various alternatives to a range of petroleum-sourced products for the consumer care, specialty chemical, and transportation fuel markets worldwide. The company was founded in 2003 and is based in Emeryville, California.


AMRS Latest News Stream


Event/Time News Detail
Loading, please wait...

AMRS Latest Social Stream


Loading social stream, please wait...

View Full AMRS Social Stream

Latest AMRS News From Around the Web

Below are the latest news stories about Amyris Inc that investors may wish to consider to help them evaluate AMRS as an investment opportunity.

Amyris to Present at the Virtual Morgan Stanley 6th Annual Sustainable Futures Conference on June 9, 2021

Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands, today announced that John Melo, Director, President and Chief Executive Officer, will participate in a virtual fireside chat at the Morgan Stanley 6th Annual Sustainable Futures Conference on Wednesday, June 9th at 3:30 pm ET.

Yahoo | June 2, 2021

Why Amyris, Gevo, and Aemetis Stocks Popped Wednesday

One of these things is (no longer) like the others.

The Motley Fool | May 27, 2021

Amyris CEO on the company's Q1 earnings report

John Melo, Amyris CEO, joined Yahoo Finance Live to discuss the company's first-quarter earnings report and why the company is teaming up with Ingredion.

Yahoo | May 11, 2021

Amyris to Present at the Virtual Morgan Stanley Global Consumer Ingredients Day on May 18, 2021

Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands, today announced that management will participate in a fireside chat at the virtual Morgan Stanley Global Consumer Ingredients Day on Tuesday, May 18th at 10:45 am ET.

Yahoo | May 11, 2021

Amyris Brand Pipette™ Partners With Baby2baby To Help Babies And Families In Need

Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company in Clean Health and Beauty markets through its consumer brands and a top supplier of sustainable and natural ingredients, today announced that Pipette™, its clean baby and mothers skincare brand, will partner with non-profit organization, Baby2Baby to donate 200,000 units of its award-winning hand sanitizer to families living in poverty nationwide.

Yahoo | May 5, 2021

Read More 'AMRS' Stories Here

AMRS Price Returns

1-mo 34.19%
3-mo -26.79%
6-mo 283.82%
1-year 304.65%
3-year 188.40%
5-year 108.80%
YTD 153.60%
2020 99.84%
2019 -7.49%
2018 -10.93%
2017 -65.75%
2016 -54.94%

Continue Researching AMRS

Want to see what other sources are saying about Amyris Inc's financials and stock price? Try the links below:

Amyris Inc (AMRS) Stock Price | Nasdaq
Amyris Inc (AMRS) Stock Quote, History and News - Yahoo Finance
Amyris Inc (AMRS) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 1.0235 seconds.